Aikido Pharma Inc reports results for the quarter ended in September - Earnings Summary

Dominari Holdings

11/11/2022 07:10

* Aikido Pharma Inc  AIKI.OQ  reported a quarterly adjusted
loss
of $1.17​​ per share for the quarter ended in September. The
lone analyst forecast for the quarter was for a loss of 77 cents
per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Aikido Pharma Inc's reported EPS for the quarter was a
loss of
$1.17​.
    * The mean earnings estimate of analysts had fallen by
about 13.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Aikido Pharma Inc shares had fallen by 37.9% this
quarter and
lost 57.4% so far this year.
    * The company reported a quarterly loss of $6.24 million.
    * Wall Street's median 12-month price target for Aikido
Pharma Inc
is $36.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
11 at 07:10 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.77          -1.17          Missed
 Jun. 30 2022      -0.68          -1.18          Missed
 Mar. 31 2022      -0.34          -0.68          Missed
 Dec. 31 2021      -0.17          -0.34          Missed